Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular Safety of Articaine (AG-920) in Healthy Subjects
NCT05501860Phase 3Completed
- Sponsor
- American Genomics
- Start
- Jul 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of articaine in ocular anesthesia, sponsored by American Genomics. Started Jul 2022; status: completed.
02
Drugs
articaine
03
Conditions
ocular anesthesia
Beyond the preview
Go deeper on NCT05501860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05501860.